Sex steroids deficiency impairs glucose transporter 4 expression and its translocation through defective Akt phosphorylation in target tissues of adult male rat

Metabolism: Clinical and Experimental

Volumn 58, Issue 11, 2009, Pages 1581-1592

  Muthusamy, Thirupathi ^a   Murugesan, Palaniappan ^b   Balasubramanian, Karundevi ^a  

^a UNIVERSITY OF MADRAS   (India)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; PROTEIN KINASE B; SEX HORMONE; TESTOSTERONE; GLUCOSE; GLYCOGEN PHOSPHORYLASE; ONCOPROTEIN; SLC2A2 PROTEIN, RAT; SLC2A4 PROTEIN, RAT;

ADIPOSE TISSUE; ANDROGEN DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; ORCHIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; ANIMAL; BIOSYNTHESIS; CELL MEMBRANE; GLYCOGEN LIVER LEVEL; METABOLISM; PHOSPHORYLATION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; WESTERN BLOTTING; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CELL MEMBRANE; ESTRADIOL; GLUCOSE; GLUCOSE TRANSPORTER TYPE 2; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN PHOSPHORYLASE; GONADAL STEROID HORMONES; LIVER; LIVER GLYCOGEN; MALE; MUSCLE, SKELETAL; ONCOGENE PROTEIN V-AKT; ORCHIECTOMY; PHOSPHORYLATION; PROTEIN TRANSPORT; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TESTOSTERONE;

EID: 70449728067     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.05.010     Document Type: Article

References (81)

1. Messing E.M., Manola J., Sarosdy M., Wilding G., Crawford E.D., and Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341 (1999) 1781-1788
2. Bubley G.J., Carducci M., Dahut W., Dawson N., Daliani D., Eisenberger M., et al. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol 17 (1999) 3461-3467
3. Shahani S., Braga-Basaria M., and Basaria S. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab 93 (2008) 2042-2049
4. Basaria S., and Dobs A.S. Hypogonadism and androgen replacement therapy in elderly men. Am J Med 110 (2001) 563-572
5. Kapoor D., Malkin C.J., Channer K.S., and Jones T.H. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 63 (2005) 239-250
6. Spark R.F. Testosterone, diabetes mellitus, and the metabolic syndrome. Curr Urol Rep 8 (2007) 467-471
7. Oh J.Y., Barrett-Connor E., Wedick N.M., and Wingard D.L. Rancho Bernardo Study. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo Study. Diabetes Care 25 (2002) 55-60
8. Laaksonen D.E., Niskanen L., Punnonen K., Nyyssönen K., Tuomainen T.P., Valkonen V.P., et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27 (2004) 1036-1041
9. Muller M., Grobbee D.E., den Tonkelaar I., Lamberts S.W., and van der Schouw Y.T. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 90 (2005) 2618-2623
10. Pitteloud N., Hardin M., Dwyer A.A., Valassi E., Yialamas M., Elahi D., et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab 90 (2005) 2636-2641
11. Selvin E., Feinleib M., Zhang L., Rohrmann S., Rifai N., Nelson W.G., et al. Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 30 (2007) 234-238
12. Mårin P., Holmäng S., Jönsson L., Sjöström L., Kvist H., Holm G., et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16 (1992) 991-997
13. Pagotto U., Gambineri A., Pelusi C., Genghini S., Cacciari M., Otto B., et al. Testosterone replacement therapy restores normal ghrelin in hypogonadal men. J Clin Endocrinol Metab 88 (2003) 4139-4143
14. Yialamas M.A., Dwyer A.A., Hanley E., Lee H., Pitteloud N., and Hayes F.J. Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 92 (2007) 4254-4259
15. Holmang A., and Bjorntorp P. The effects of testosterone on insulin sensitivity in male rats. Acta Physiol Scand 146 (1992) 505-510
16. Morimoto S., Fernandez-Mejia C., Romero-Navarro G., Morales-Peza N., and Díaz-Sánchez V. Testosterone effect on insulin content, messenger ribonucleic acid levels, promoter activity, and secretion in the rat. Endocrinology 142 (2001) 1442-1447
17. Bhasin S. Effects of testosterone administration on fat distribution, insulin sensitivity, and atherosclerosis progression. Clin Infect Dis 37 Suppl 2 (2003) S142-S149
18. Livingstone C., and Collison M. Sex steroids and insulin resistance. Clin Sci (Lond) 102 (2002) 151-166
19. Woodard T.L., Burghen G.A., Kitabchi A.E., and Wilimas J.A. Glucose intolerance and insulin resistance in aplastic anemia treated with oxymetholone. J Clin Endocrinol Metab 53 (1981) 905-908
20. Cohen J.C., and Hickman R. Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. J Clin Endocrinol Metab 64 (1987) 960-963
21. Mårin P., Holmäng S., Gustafsson C., Jönsson L., Kvist H., Elander A., et al. Androgen treatment of abdominally obese men. Obes Res 1 (1993) 245-251
22. Takeda K., Toda K., Saibara T., Nakagawa M., Saika K., Onishi T., et al. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 176 (2003) 237-246
23. Maffei L., Murata Y., Rochira V., Tubert G., Aranda C., Vazquez M., et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 89 (2004) 61-70
24. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331 (1994) 1056-1061
25. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., and Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 97 (2000) 12729-12734
26. Bilezikian J.P., Morishima A., Bell J., and Grumbach M.M. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 339 (1998) 599-603
27. Muthusamy T., Dhevika S., Murugesan P., and Balasubramanian K. Testosterone deficiency impairs glucose oxidation through defective insulin and its receptor gene expression in target tissues of adult male rats. Life Sci 81 (2007) 534-542
28. Pessin J.E., and Saltiel A.R. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106 (2000) 165-169
29. Defronzo R.A., and Mandarino L.J. 2003 Insulin actions. In: Henry H., and Norman A. (Eds). Encyclopedia of hormones (2003), Elseivier Inc., California 333-347
30. Kolterman O.G., Gray R.S., Griffin J., Burstein P., Insel J., Scarlett J.A., et al. Receptor and postreceptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. J Clin Invest 68 (1981) 957-969
31. Liu J., Tsang S., and Wong T.M. Testosterone is required for delayed cardioprotection and enhanced heat shock protein 70 expression induced by preconditioning. Endocrinology 147 (2006) 4569-4577
32. Oparil S., Levine R.L., Chen S.J., Durand J., and Chen Y.F. Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. Circulation 95 (1997) 1301-1307
33. Dickson R.B., Aten R.F., and Eisenfeld A.J. An unusual sex steroid-binding protein in mature male rat liver cytosol. Endocrinology 103 (1978) 1636-1646
34. Ariano M.A., Armstrong R.B., and Edgerton V.R. Hindlimb muscle fiber populations of five mammals. J Histochem Cytochem 21 (1973) 51-55
35. Catalano K.J., Bergman R.N., and Ader M. Increased susceptibility to insulin resistance associated with abdominal obesity in aging rats. Obes Res 13 (2005) 11-20
36. Collins S., Ahima R.S., and Kahn B.B. Biology of adipose tissue. In: Kahn C.R., King G.L., Moses A.C., Weir G.C., Jacobson A.M., and Smith R.J. (Eds). Joslin's diabetes Mellitus (2005), A Wolters Klunwer Company, Indian edition by BI publication, India 207-226
37. Riley V. Adaptation of orbital bleeding technic to rapid serial blood studies. Proc Soc Exp Biol Med 104 (1960) 751-754
38. Liu Y., Wan Q., Guan Q., Gao L., and Zhao J. High-fat diet feeding impairs both the expression and activity of AMPKa in rats' skeletal muscle. Biochem Biophys Res Commun 339 (2006) 701-707
39. Houghton S.G., Zarroug A.E., Duenes J.A., Fernandez-Zapico M.E., and Sarr M.G. The diurnal periodicity of hexose transporter mRNA and protein levels in the rat jejunum: role of vagal innervation. Surgery 139 (2006) 542-549
40. Peinnequin A., Mouret C., Birot O., Alonso A., Mathieu J., Clarençon D., et al. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 5 (2004) 3
41. Dombrowski L., Roy D., Marcotte B., and Marette A. A new procedure for the isolation of plasma membranes, T tubules, and internal membranes from skeletal muscle. Am J Physiol 270 (1996) E667-E676
42. Nevado C., Valverde A.M., and Benito M. Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes. Endocrinology 147 (2006) 3709-3718
43. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
44. Valverde A.M., Lorenzo M., Navarro P., Mur C., and Benito M. Okadaic acid inhibits insulin-induced glucose transport in fetal brown adipocytes in an Akt-independent and protein kinase C zeta-dependent manner. FEBS Lett 472 (2000) 153-158
45. Leloir L.F., and Goldemberg S.H. Glycogen synthetase from rat liver. In: Colowick S.P., and Kaplan N.O. (Eds). Methods in enzymology vol. V (1962), Academic Press, New York 145-146
46. Cornblath M., Randle P.J., Parmeggiani A., and Morgan H.E. Regulation of glycogenolysis in muscle. Effects of glucagon and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart. J Biol Chem 238 (1963) 1592-1597
47. Hassid W.Z., and Abraham S. Chemical procedures for analysis of polysaccharides. I. Determination of glycogen and starch. Determination of glycogen with anthrone reagent. Methods Enzymol 3 (1957) 35-36
48. Bryant N.J., Govers R., and James D.E. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3 (2002) 267-277
49. Sato K., Iemitsu M., Aizawa K., and Ajisaka R. Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle. Am J Physiol Endocrinol Metab 294 (2008) E961-E968
50. Rincon J., Holmäng A., Wahlström E.O., Lönnroth P., Björntorp P., Zierath J.R., et al. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 45 (1996) 615-621
51. Marette A., Burdett E., Douen A., Vranic M., and Klip A. Insulin induces the translocation of GLUT4 from a unique intracellular organelle to transverse tubules in rat skeletal muscle. Diabetes 41 (1992) 1562-1569
52. Ploug T., van Deurs B., Ai H., Cushman S.W., and Ralston E. Analysis of GLUT4 distribution in whole skeletal muscle fibers: identification of distinct storage compartments that are recruited by insulin and muscle contractions. J Cell Biol 142 (1998) 1429-1446
53. Saltiel A.R., and Khan C.R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 41 (2001) 799-806
54. Welsh G.I., Hers I., Berwick D.C., Dell G., Wherlock M., Birkin R., et al. Role of protein kinase B in insulin-regulated glucose uptake. Biochem Soc Trans 33 (2005) 346-349
55. Coffer P.J., Jin J., and Woodgett J.R. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335 (1998) 1-13
56. Vanhaesebroeck B., and Alessi D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346 (2000) 561-576
57. Kang H.Y., Cho C.L., Huang K.L., Wang J.C., Hu Y.C., Lin H.K., et al. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts. J Bone Miner Res 19 (2004) 1181-1190
58. Nagira K., Sasaoka T., Wada T., Fukui K., Ikubo M., Hori S., et al. Altered subcellular distribution of estrogen receptor alpha is implicated in estradiol-induced dual regulation of insulin signaling in 3T3-L1 adipocytes. Endocrinology 147 (2006) 1020-1028
59. Hsu J.T., Kan W.H., Hsieh C.H., Choudhry M.A., Schwacha M.G., Bland K.I., et al. Mechanism of estrogen-mediated intestinal protection following trauma-hemorrhage: p38 MAPK-dependent upregulation of HO-1. Am J Physiol Regul Integr Comp Physiol 94 (2008) R1825-R1831
60. Rogers N.H., Witczak C.A., Hirshman M.F., Goodyear L.J., and Greenberg A.S. Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochem Biophys Res Commun 382 (2009) 646-650
61. Virkamäki A., Ueki K., and Kahn C.R. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103 (1999) 931-943
62. Chen X., Li X., Huang H.Y., Li X., and Lin J.F. Effects of testosterone on insulin receptor substrate-1 and glucose transporter 4 expression in cells sensitive to insulin. Zhonghua Yi Xue Za Zhi 86 (2006) 1474-1477
63. Granner D.K., and Scott D.K. Regulation of hepatic glucose metabolism. In: Kahn C.R., King G.L., Moses A.C., Weir G.C., Jacobson A.M., and Smith R.J. (Eds). Joslin's diabetes mellitus (2005), A Wolters Kluwer Company, Indian edition by BI publication, India 243-263
64. Valverde A.M., Navarro P., Teruel T., Conejo R., Benito M., and Lorenzo M. Insulin and insulin-like growth factor I up-regulate GLUT4 gene expression in fetal brown adipocytes, in a phosphoinositide 3-kinase-dependent manner. Biochem J 337 (1999) 397-405
65. Ramamani A., Aruldhas M.M., and Govindarajulu P. Differential response of rat skeletal muscle glycogen metabolism to testosterone and estradiol. Can J Physiol Pharmacol 77 (1999) 300-304
66. Thomas J.L., Quang B.T., Ochsenbein E., and Vincent J.P. Relationship between some biological parameters and plasma testosterone in institutionalized aging men. J Nutr Health Aging 7 (2003) 437-439
67. Rencurel F., Waeber G., Antoine B., Rocchiccioli F., Maulard P., Girard J., et al. Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver. Biochem J 314 (1996) 903-909
68. Nordlie R.C., Foster J.D., and Lange A.J. Regulation of glucose production by the liver. Annu Rev Nutr 19 (1999) 379-406
69. Im S.S., Kang S.Y., Kim S.Y., Kim H.I., Kim J.W., Kim K.S., et al. Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes. Diabetes 54 (2005) 1684-1691
70. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J 414 (2008) 1-18
71. Lawlor M.A., and Alessi D.R. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J Cell Sci 114 (2001) 2903-2910
72. Ono H., Shimano H., Katagiri H., Yahagi N., et al. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes 52 (2003) 2905-2913
73. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw III E.B., et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292 (2001) 1728-1731
74. Cho H., Thorvaldsen J.L., Chu Q., Feng F., and Birnbaum M.J. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276 (2001) 38349-38352
75. Cato A.C., and Peterziel H. The androgen receptor as mediator of gene expression and signal transduction pathways. Trends Endocrinol Metab 9 (1998) 150-154
76. Mayes J.S., and Watson G.H. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 5 (2004) 197-216
77. McEwan I.J., and Gustafsson J. Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proc Natl Acad Sci USA 94 (1997) 8485-8490
78. Yeh S., and Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 93 (1996) 5517-5521
79. Aarnisalo P., Palvimo J.J., and Jänne O.A. CREB-binding protein in androgen receptor-mediated signaling. Proc Natl Acad Sci USA 95 (1998) 2122-2127
80. Kahn C.R., Goldfine I.D., Neville D.M., and De Meyts P. Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone. Endocrinology 103 (1978) 1054-1066
81. Burén J., Liu H.X., Jensen J., and Eriksson J.W. Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes. Eur J Endocrinol 146 (2002) 419-429